Search by Drug Name or NDC
NDC 00363-0396-34 wal tussin dm 20; 200 mg/10mL; mg/10mL Details
wal tussin dm 20; 200 mg/10mL; mg/10mL
wal tussin dm is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Walgreen Company. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 00363-0396-34Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 00363-0396-34Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 00363-0396 |
---|---|
Product ID | 0363-0396_ee385dff-e56d-46de-a5aa-a96847634941 |
Associated GPIs | 43997002520910 |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | wal tussin dm |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Dextromethorphan HBr, Guaifenesin |
Product Type | HUMAN OTC DRUG |
Dosage Form | SOLUTION |
Route | ORAL |
Active Ingredient Strength | 20; 200 |
Active Ingredient Units | mg/10mL; mg/10mL |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Labeler Name | Walgreen Company |
Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00363-0396-34 (00363039634)
NDC Package Code | 0363-0396-34 |
---|---|
Billing NDC | 00363039634 |
Package | 1 BOTTLE in 1 CARTON (0363-0396-34) / 237 mL in 1 BOTTLE |
Marketing Start Date | 1995-10-20 |
NDC Exclude Flag | N |
Pricing Information | N/A |